Orchestra BioMed Holdings, Inc. (OBIO)
NASDAQ: OBIO · Real-Time Price · USD
4.220
+0.050 (1.20%)
At close: Jan 16, 2026, 4:00 PM EST
4.280
+0.060 (1.42%)
After-hours: Jan 16, 2026, 7:00 PM EST
Orchestra BioMed Holdings Employees
Orchestra BioMed Holdings had 70 employees as of December 31, 2024. The number of employees increased by 14 or 25.00% compared to the previous year.
Employees
70
Change (1Y)
14
Growth (1Y)
25.00%
Revenue / Employee
$40,257
Profits / Employee
-$1,072,871
Market Cap
238.28M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 70 | 14 | 25.00% |
| Dec 31, 2023 | 56 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
OBIO News
- 5 days ago - Orchestra BioMed to Receive Up to $21 Million in Proceeds from Acquisition of Vivasure by Haemonetics - GlobeNewsWire
- 5 weeks ago - Orchestra BioMed Announces AVIM Therapy and Virtue SAB Program Presentations at ICI Meeting - GlobeNewsWire
- 7 weeks ago - Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 2 months ago - Orchestra BioMed to Participate in Upcoming Institutional Investor Conferences - GlobeNewsWire
- 2 months ago - Orchestra BioMed Reports Third Quarter 2025 Financial Results and Highlights Recent Business Updates - GlobeNewsWire
- 2 months ago - Orchestra BioMed to Host Business Update Call on November 12, 2025 - GlobeNewsWire
- 2 months ago - Orchestra BioMed and Terumo Enter into New $30 Million Virtue SAB Strategic Agreements - GlobeNewsWire
- 2 months ago - Orchestra BioMed Announces First Patients Enrolled in Virtue® SAB US Pivotal IDE Coronary Trial - GlobeNewsWire